日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Global cancer statistics for children: Two decades of change and projections to 2050

全球儿童癌症统计数据:二十年来的变化及至2050年的预测

Li, Wangzhong; Huang, Shanzhou; Chen, Qiyue; Wang, Ting; Lu, Guanming; Niu, Xing; Song, Qiong; Xu, Yilin; Mo, Ke; Cui, Chunhui; Zhang, Run; Du, Wei; He, Feiying; Shi, Lei; Lin, Yan; Wei, Qiu; Jiang, Li; Chen, Yongsheng; Song, Baiyang; Zhang, Huijuan; Fu, Zhenli; Liao, Wenjing; Sun, Jiancong; Guan, Wenhui; Zhuang, Weitao; Zhong, Nanshan; Zhou, Chengzhi; Liang, Wenhua; Kang, Min; He, Jianxing

Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study

奥莫替尼联合卡铂-培美曲塞对比奥莫替尼单药治疗EGFR和伴随肿瘤抑制基因的非小细胞肺癌(ACROSS2):一项开放标签、多中心、随机3期研究

Duan, Jian-Chun; Zhong, Jia; Sun, Bo-Yang; Zhao, Wen-Hua; Wu, Lin; Fei, Kai-Lun; Chu, Qian; Guo, Qi-Sen; Song, Qi-Bin; Yu, Yan; Zhu, Da-Xing; Liu, Xin-Yan; Zhao, Jun; Zhan, Zhi-Xiang; Li, Shi; Nie, Lei; Lin, Jie; Peng, Xiao-Dong; Zhong, Dian-Sheng; Zhou, Jin; Li, Li-Hua; Chen, Yun-Fang; Hu, Chen; Mok, Tony; Wang, Zhi-Jie; Wang, Jie

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial

一项多中心、随机、双盲、安慰剂对照的3期临床试验:在初诊晚期卵巢癌患者中,使用氟哌啶醇联合或不联合阿帕替尼作为维持治疗方案的疗效评价(FZOCUS-1):一项多中心、随机、双盲、安慰剂对照试验

Wu, Lingying; Wang, Jing; Li, Qingshui; Wang, Danbo; Zhang, Cuiying; Tang, Junying; Zhang, Guonan; Hao, Min; Yao, Desheng; Gao, Qinglei; Zhang, Youzhong; An, Ruifang; Yin, Rutie; Wang, Li; Xia, Bairong; Zhou, Qi; Yang, Hongying; Zhu, Jianqing; Jiang, Kui; Chen, Zhengzheng; Wu, Qiang; Duan, Wei; Huang, Yi; Zhang, Hui; Wei, Shuqing; Li, Guiling; Meng, Yuanguang; Wang, Ke; Yang, Xinfeng; Huang, Xianghua; Pan, Lingya; Yu, Jinjin; Lou, Ge; Zhang, Yu; Zhou, Huaijun; Guo, Xiaoqing; Yang, Hong; Cheng, Xiaodong; Li, Xiumin; Wang, Wuliang; Zhao, Hongqin; Li, Yunxia; Yang, Yingjie; Lin, An; Cheng, Wenjun; Chen, Lihong; Xie, Xiaoying; Di, Wen; Hu, Yuanjing; Chen, Mo; Wen, Hongwu; Cai, Liping; Wu, Xiaohua; Lin, Zhongqiu; Wang, Quanren; Yang, Xinfeng; Li, Ning

The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study

非小细胞肺癌软脑膜转移的演变格局:一项国际性、当代、多中心队列研究

Zheng, M M; Xia, Y; Pan, K; Sun, F; Tan, A C; Dong, X R; Tu, H Y; Tang, L B; Li, Y S; Yin, K; Borgeaud, M; Singhal, S; Zhu, E; Zhang, J; Nilsson, M; Wu, J; Gibbons, D L; Wakelee, H; Neal, J W; Lee, J; Vaporciyan, A A; Ringsurongkawong, W; Tran, H T; Zhang, R Z; Zhang, T; Zhou, Q; Zhong, W Z; Li, W; Zhang, Y C; Riess, J W; Addeo, A; Heymach, J V; Myall, N; Tan, D; Wu, Y L; Le, X

Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Randomized Clinical Trial

Tucidinostat Plus R-CHOP vs R-CHOP 治疗 MYC/BCL2 双表达弥漫性大 B 细胞淋巴瘤:一项随机临床试验

Xu, Peng-Peng; Song, Yu-Qin; Shen, Jian-Zhen; Cai, Qing-Qing; Zhou, Hui; Zhang, Li-Ling; Xiang, Ying; Sun, Xiu-Hua; Yang, Wei; Yao, Zhi-Hua; Jing, Hong-Mei; Wen, Shu-Juan; Jin, Jie; Xue, Hong-Wei; Cen, Hong; Ding, Kai-Yang; Jin, Zheng-Ming; Liu, Li-Hong; Xing, Xiao-Jing; Li, Lan-Fang; Hou, Ming; Liu, Lin; Zhang, Ming-Zhi; Li, Wen-Yu; Bai, Ou; Feng, Ru; Zhu, Zun-Min; Wu, Hui-Jing; Su, Li-Ping; Gao, Li; Li, Fei; Huang, Wen-Rong; Liu, Peng; Yan, Xiao-Jing; Zhao, Ying; Su, Hang; Zhao, Xie-Lan; Fu, Rong; Liu, Hong; Shi, Wen-Yu; Li, Hui-Zhi; Chen, Bo; Ning, Zhi-Qiang; Zhu, Jun; Zhao, Wei-Li

Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After Ischemic Stroke: The OPTION Randomized Clinical Trial

替奈普酶治疗缺血性卒中后 4.5 至 24 小时内的急性非大血管闭塞:OPTION 随机临床试验

Ma, Gaoting; Mo, Ran; Zuo, Yingting; Ma, Qingfeng; Zhao, Guangjian; Yao, Xiaoxi; Liang, Ji; Zhou, Li; He, Yong; Long, Faqing; Yuan, Zhengzhou; Liu, Lei; Han, Guosheng; Tan, Yan; Ai, Zhibing; Cai, Chunsheng; Liu, Juan; Zhang, Liyong; Yang, Haihua; Yi, Tingyu; Li, Li; Fu, Yao; Zhang, Yanxing; Shao, Xiangzhong; Yu, Zhipeng; Wu, Saizhen; Du, Yanqiu; Mao, Lingqun; Guo, Hongling; Chen, Xufeng; Chen, Yifei; Zhao, Qiong; Chi, Liyi; Liu, Yi; Zhang, Haochun; Li, Guangzong; Meng, Shujuan; Wu, Yifan; Wu, Jieying; Jiang, Ziying; Lei, Shaoyuan; Gao, Daiquan; Zhong, Lianmei; Fiehler, Jens; Wang, Duolao; Nguyen, Thanh N; Saver, Jeffrey L; Hao, Junwei

BMAL1 regulates circadian rhythms via phase separation-mediated transcriptional hub formation

BMAL1通过相位分离介导的转录中心形成来调控昼夜节律。

Gao, Wenzhen; Zhu, Li; Wei, Yali; Luo, Guowen; Wang, Jiahe; Wang, Lijie; Peng, Zhengying; Li, Xuan; Wu, Zhuoxuan; Li, Jingyi; Wu, Yanfen; Wang, Xiaoxiao; Jing, Junjun; Zou, Shujuan; Zhao, Qing; Fan, Yi; Yuan, Quan; Zhou, Chenchen

Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer

靶向损伤相关巨噬细胞中的GPR34可增强抗肿瘤免疫力并提高苏鲁替尼在胰腺癌中的疗效

Guo, Xiaofan; Liu, Yuxiao; Li, Tianchen; An, Xiaopeng; Song, Yuning; Xu, Peijun; Huang, Jing; Zou, Yiping; Xu, Bohang; Xie, Yongjie; Li, Zekun; Meng, Chenyang; Zhao, Tiansuo; Wang, Xiuchao; Wang, Hongwei; Gao, Chuntao; Zhou, Xuan; Yu, Jun; Gao, Song; Hao, Jihui

Endothelial GABA protects against aortic dissection by inhibiting endothelial and mitochondrial dysfunction and maintaining vascular homeostasis

内皮细胞中的GABA通过抑制内皮和线粒体功能障碍并维持血管稳态来预防主动脉夹层。

Shao, Lianbo; Yu, You; Huang, Haoyue; Chen, Yihuan; Teng, Xiaomei; Shen, Han; Ding, Yinglong; Zhou, Yihong; Wang, Tingyu; Shen, Zhenya

Robust neurogenesis in chronic stroke monkeys following mesenchymal stem cell transplantation plus intermittent theta-burst stimulation

间充质干细胞移植联合间歇性θ节律刺激后,慢性中风猴体内神经发生显著增强

Ma, Yuan-Huan; Chen, Geng-Bin; Wu, Man-Feng; Li, Ge; Zhang, Yu; Lv, Jian-Ping; Wen, Min; Cai, Lei; Zhang, Cai-Ling; Jiang, Jun-Bo; Zhang, Ke; Zhang, Ke-Jun; Liu, Ying; Liu, Zhou; Chen, Jia-Lin; Lin, Tuo; Wang, Li-Xin; Xu, Guang-Qing; Zeng, Xiang; Lan, Yue